AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

RHYTHM BIOSCIENCES LTD

0.190

0.000

Volume:261.93K

Turnover:50.13K

Market Cap:63.66M

PE:-8.54

High:0.195

Open:0.195

Low:0.190

Close:0.190

52wk High:0.280

52wk Low:0.047

Shares:335.03M

Float Shares:188.31M

Volume Ratio:0.79

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.022

EPS(LYR):-0.014

ROE:-190.14%

ROA:-91.40%

PB:29.70

PE(LYR):-13.36

Loading ...

Overview Company News Filings

Rhythm Biosciences Biosciences Secures Strategic Alliance With AGRF

Rhythm Biosciences Ltd - Partnership to Accelerate Commercial Scale-up of Genetype Service

THOMSON REUTERS

Rhythm Biosciences Ltd - Rhythm Biosciences Secures Strategic Alliance With Agrf

THOMSON REUTERS

BRIEF-Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQ

Rhythm Biosciences Ltd - Secures Strategic US Partnership With Cancer Iq

THOMSON REUTERS

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

Rhythm Biosciences Partners with datma to Advance Genomic Cancer Diagnostics

Datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development

THOMSON REUTERS

BUZZ-Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test

BRIEF-Rhythm Biosciences Says CFO Todd Perkinson To Leave

Rhythm Biosciences - CFO Todd Perkinson to Leave

THOMSON REUTERS

Rhythm Biosciences Ltd-Departure of Chief Financial Officer

THOMSON REUTERS

BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration

BRIEF-Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation Trust

Rhythm Biosciences Ltd - Entered a Collaboration With Southern Hub Research Team, Royal Surrey Nhs Foundation Trust

THOMSON REUTERS

Rhythm Biosciences - Collaboration to Evaluate Suitability of Colostat for Potential Use Within Bowel Cancer Screening Pathway in England

THOMSON REUTERS

BRIEF-Rhythm Biosciences Enters A Us Marketing Partnership With Catch Bio

Rhythm Biosciences Ltd - Enters a US Marketing Partnership With Catch Bio

THOMSON REUTERS

Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair

BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RHY.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.19,"timestamp":1776393407769,"preClose":0.19,"halted":0,"volume":261928,"delay":0,"changeRate":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":335032850,"eps":-0.022243,"marketStatus":"Trading","change":0,"latestTime":"04-17 12:56:24 AEST","open":0.195,"high":0.195,"low":0.19,"amount":50129,"amplitude":0.026316,"askPrice":0.19,"askSize":10965,"bidPrice":0.185,"bidSize":29778,"shortable":3,"etf":0,"ttmEps":-0.022243,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1776405600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.19,"openAndCloseTimeList":[[1776384000000,1776405600000]],"volumeRatio":0.794034,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RHY.AU","preClose":0.19,"auctionPrice":0.195,"auctionVolume":3076,"auctionTime":1776383880876,"referenceTime":1776335404095,"auction":1,"marketStatus":"盘前竞价","timestamp":1776383880876}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-91.40%","roe":"-190.14%","lyrEps":-0.014222,"volumeRatio":0.794034,"shares":335032850,"dividePrice":0,"high":0.195,"amplitude":0.026316,"preClose":0.19,"low":0.19,"week52Low":0.047,"pbRate":"29.70","psRate":"38.63","week52High":0.28,"institutionHeld":0,"latestPrice":0.19,"committee":0.461748,"eps":-0.022243,"divideRate":0,"volume":261928,"delay":0,"ttmEps":-0.022243,"open":0.195,"prevYearClose":0.135,"prevWeekClose":0.187,"prevMonthClose":0.18,"prevQuarterClose":0.18,"fiveDayClose":0.187,"twentyDayClose":0.235,"sixtyDayClose":0.15,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RHY.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607778822","title":"Rhythm Biosciences Biosciences Secures Strategic Alliance With AGRF","url":"https://stock-news.laohu8.com/highlight/detail?id=2607778822","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607778822?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:42","pubTimestamp":1769650978,"startTime":"0","endTime":"0","summary":"Jan 29 (Reuters) - Rhythm Biosciences Ltd ::*RHYTHM BIOSCIENCES SECURES STRATEGIC ALLIANCE WITH AGRF*PARTNERSHIP TO ACCELERATE COMMERCIAL SCALE-UP OF GENETYPE SERVICE*Further company coverage: RHY.AX*","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nRSDbk2JCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607725773","title":"Rhythm Biosciences Ltd - Partnership to Accelerate Commercial Scale-up of Genetype Service","url":"https://stock-news.laohu8.com/highlight/detail?id=2607725773","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607725773?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:09","pubTimestamp":1769638193,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607224725","title":"Rhythm Biosciences Ltd - Rhythm Biosciences Secures Strategic Alliance With Agrf","url":"https://stock-news.laohu8.com/highlight/detail?id=2607224725","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607224725?lang=en_us&edition=fundamental","pubTime":"2026-01-29 06:09","pubTimestamp":1769638193,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT16P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606575721","title":"BRIEF-Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2606575721","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606575721?lang=en_us&edition=fundamental","pubTime":"2026-01-28 09:37","pubTimestamp":1769564221,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQJan 28 (Reuters) - Rhythm Biosciences Ltd RHY.AX:SECURES STRATEGIC US PARTNERSHIP WITH CANCER IQFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YS1B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606755021","title":"Rhythm Biosciences Ltd - Secures Strategic US Partnership With Cancer Iq","url":"https://stock-news.laohu8.com/highlight/detail?id=2606755021","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606755021?lang=en_us&edition=fundamental","pubTime":"2026-01-28 06:23","pubTimestamp":1769552614,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS1B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603665390","title":"Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665390","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603665390?lang=en_us&edition=fundamental","pubTime":"2026-01-14 11:40","pubTimestamp":1768362000,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ --Rhythm Biosciences Ltd  , a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer  Risk Assessment clinical test , a significant advancement in personalised cancer risk prediction. The updated test incorporates additional clinical and lifestyle risk factors alongside the established 140-SNP polygenic risk score , delivering improved predictive accuracy across both genders and a wider age range.The enhanced test is designed to support earlier identification of individuals at elevated risk of colorectal cancer, enabling more targeted screening pathways and complementing Rhythm's ColoSTAT blood-based CRC detection test.Validation data for the updated model has been recently published in the peer-reviewed journal PLOS ONE , demonstrating improved predictive performance compared to traditional approaches.Rhythm Biosciences Ltd  is an Australi","market":"us","thumbnail":"https://mma.prnewswire.com/media/2861328/Rhythm_Biosciences_Vert_CMYK_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2861328/Rhythm_Biosciences_Vert_CMYK_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/enhanced-genetype-colorectal-cancer-risk-test-released--supports-earlier-disease-detection-and-colostat-targeting-302660578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","BK4213","PRS","BK7124","CRC","RHY.AU","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593480808","title":"Rhythm Biosciences Partners with datma to Advance Genomic Cancer Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2593480808","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593480808?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:04","pubTimestamp":1766408679,"startTime":"0","endTime":"0","summary":"Rhythm Biosciences Ltd. has announced an exploratory collaboration with datma, a leader in federated real-world data access, to evaluate how datma's federated data platform, datma.FED, can support and accelerate the commercialization of Rhythm's genomic-integrated cancer risk prediction portfolio. The partnership will focus on leveraging longitudinal, de-identified real-world clinical data to aid in the development of Rhythm's geneType risk assessment tool, supporting clinical utility evidence generation and health economic modelling. This collaboration aims to enhance the clinical relevance and adoption of population-based cancer risk stratification tools.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rhythm Biosciences Ltd. publishe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLbq9mfr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593487705","title":"Datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2593487705","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593487705?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:00","pubTimestamp":1766408404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nTUAJ1LWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590297875","title":"BUZZ-Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test","url":"https://stock-news.laohu8.com/highlight/detail?id=2590297875","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590297875?lang=en_us&edition=fundamental","pubTime":"2025-12-12 11:08","pubTimestamp":1765508890,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test** Shares of Australia's Rhythm Biosciences  RHY.AX jump 38.6% to A$0.115, set for best day since August 6 if gains hold ** Stock at highest since October 15 ** Cancer diagnostics tech firm commences commercialisation of its flagship blood-based colorectal cancer test - ColoSTAT** YTD shares up 32.2%   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nL6N3XI05X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590377195","title":"BRIEF-Rhythm Biosciences Says CFO Todd Perkinson To Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377195","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377195?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:13","pubTimestamp":1765340026,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Says CFO Todd Perkinson To LeaveDec 10 (Reuters) - Rhythm Biosciences Ltd RHY.AX:CFO TODD PERKINSON TO LEAVEFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUE5V94DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590377166","title":"Rhythm Biosciences - CFO Todd Perkinson to Leave","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377166","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377166?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:11","pubTimestamp":1765339899,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUE5V94DB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590377161","title":"Rhythm Biosciences Ltd-Departure of Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590377161","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590377161?lang=en_us&edition=fundamental","pubTime":"2025-12-10 12:11","pubTimestamp":1765339899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nTUE5V94DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590037422","title":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2590037422","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590037422?lang=en_us&edition=fundamental","pubTime":"2025-12-10 11:17","pubTimestamp":1765336642,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Rhythm Biosciences gains on cancer test collaboration** Rhythm Biosciences RHY.AX rises as much as 5.2% to A$0.082; set for strongest trading session in more than a week** Stock hits highest since December 3** Medical diagnostics co enters collaboration with The Southern Hub Research Team, Royal Surrey NHS Foundation Trust to evaluate suitability of ColoSTAT for potential use in bowel cancer screening pathway in England** ColoSTAT test is a blood-based test used to detect colorectal cancer** YTD, RHY down ~6%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL6N3XG05W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590537631","title":"BRIEF-Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2590537631","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590537631?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:21","pubTimestamp":1765329686,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation TrustDec 10  - Rhythm Biosciences Ltd RHY.AX:ENTERED A COLLABORATION WITH SOUTHERN HUB RESEARCH TEAM, ROYAL SURREY NHS FOUNDATION TRUSTCOLLABORATION TO EVALUATE SUITABILITY OF COLOSTAT FOR POTENTIAL USE WITHIN BOWEL CANCER SCREENING PATHWAY IN ENGLANDFurther company coverage: RHY.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590322848","title":"Rhythm Biosciences Ltd - Entered a Collaboration With Southern Hub Research Team, Royal Surrey Nhs Foundation Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322848?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:55","pubTimestamp":1765317335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590322843","title":"Rhythm Biosciences - Collaboration to Evaluate Suitability of Colostat for Potential Use Within Bowel Cancer Screening Pathway in England","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322843?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:55","pubTimestamp":1765317335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0IV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590603733","title":"BRIEF-Rhythm Biosciences Enters A Us Marketing Partnership With Catch Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2590603733","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590603733?lang=en_us&edition=fundamental","pubTime":"2025-12-09 09:05","pubTimestamp":1765242304,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Enters A Us Marketing Partnership With Catch BioDec 9 (Reuters) - Rhythm Biosciences Ltd RHY.AX:ENTERS A US MARKETING PARTNERSHIP WITH CATCH BIOFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XE1BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590136633","title":"Rhythm Biosciences Ltd - Enters a US Marketing Partnership With Catch Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2590136633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590136633?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:30","pubTimestamp":1765229421,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE1BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584488925","title":"Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2584488925","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584488925?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:33","pubTimestamp":1763570020,"startTime":"0","endTime":"0","summary":"Nov 5 (Reuters) - Rhythm Biosciences Ltd ::*GAVIN FOX-SMITH APPOINTED CHAIR OF RHYTHM BIOSCIENCES*OTTO BUTTULA RETIRES AS CHAIR*Further company coverage: RHY.AX* ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDbVf1kN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RHY.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581790473","title":"BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2581790473","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581790473?lang=en_us&edition=fundamental","pubTime":"2025-11-05 10:04","pubTimestamp":1762308252,"startTime":"0","endTime":"0","summary":"BRIEF-Rhythm Biosciences Says Gavin Fox-Smith Appointed ChairNov 5 (Reuters) - Rhythm Biosciences Ltd RHY.AX:GAVIN FOX-SMITH APPOINTED CHAIR OF RHYTHM BIOSCIENCESOTTO BUTTULA RETIRES AS CHAIRFurther company coverage: RHY.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nTUE5DDR5F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","RHY.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":44,"code":"91000000","status":"200"}]}}